Proteins encoded by oncogenes such as v-fpslfes, v-src, v-yes, v-abl, and v-fgr are cytoplasmic protein tyrosine kinases which, unlike transmembrane receptors, are localized to the inside of the cell. These proteins possess two contiguous regions of sequence identity: a C-terminal catalytic domain of 260 residues with homology to other tyrosine-specific and serine-threonine-specific protein kinases, and a unique domain of approximately 100 residues which is located N terminal to the kinase region and is absent from kinases that span the plasma membrane. In-frame linker insertion mutations in Fujinami avian sarcoma virus which introduced dipeptide insertions into the most stringently conserved segment of this N-terminal domain in P130 gag-fps impaired the ability of Fujinami avian sarcoma virus to transform rat-2 cells. The P130 gag-fps proteins encoded by these transformationdefective mutants were deficient in protein-tyrosine kinase activity in rat cells. However v-fps polypeptides derived from the mutant Fujinami avian sarcoma virus genonles and expressed in Escherichia coli as trpE-v-fps fusion proteins displayed essentially wild-type enzymatic activity, even though they contained the mutated sites. Deletion of the N-terminal domain from wild-type and mutant v-fps bacterial proteins had little effect on autophosphorylating activity. The conserved Nterminal domain of P130 gag-fps is therefore not required for catalytic activity, but can profoundly influence the adjacent kinase region. The presence of this noncatalytic domain in all known cytoplasmic tyrosine kinases of higher and lower eucaryotes argues for an important biological function. The relative inactivity of the mutant proteins in rat-2 cells compared with bacteria suggests that the noncatalytic domain may direct specific interactions of the enzymatic region with cellular components that regulate or mediate tyrosine kinase function.
Many tyrosine kinases were first identified as the products of activated retroviral or cellular oncogenes in which manifestation they induce neoplastic cell growth (19) . In normal vertebrate cells protein-tyrosine kinases are apparently involved in the interpretation of mitogenic and developmental signals (19) . Both normal proteintyrosine kinases and their oncogenic counterparts can be divided into two groups based on their subcellular locations. One group contains transmembrane growth factor receptors such as those for epidermal growth factor, platelet-derived growth factor, insulin, and colony-stimulating factor 1 in which a cytoplasmic kinase domain is linked by a transmembrane segment to an extracellular ligand-binding domain (2, 11, 20, 43, 46, 59, 60) . In general, association of a hormone with its receptor stimulates the activity of the intracellular kinase domain toward cellular protein substrates (43) . The products of the verbB, v-fms, v-ros, c-neu, and trk oncogenes are apparently aberrant forms of such receptors (10, 18, 30, 33, 45) . In contrast tyrosine kinases encoded by genes such as src, fpslfes, abl, fgr, and yes have no obvious transmembrane sequence and are entirely cytoplasmic, although they are *Corresponding author.
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generally found in association with the internal face of the plasma membrane or with the cytoskeleton (14, 15, 28, 31, (39) (40) (41) (42) .
The normal functions of proteins in this latter group are less clear than those of receptors for which specific ligands can be identified. p60 c-src is expressed to high levels in postmitotic neuronal cells and platelets (8, 17, 49) , whereas synthesis of the c-fps/fes product is largely confined to cells capable of myeloid differentiation (12, 27) . Such observations have suggested that the cytoplasmic tyrosine kinases may have functions in development or differentiation.
All protein-tyrosine kinases share a region of sequence identity spanning approximately 260 amino acids which apparently corresponds to the catalytic domain. This region is released from p60 v-src and P130
gag-fps
by limited proteolysis as a C-terminal 29-kilodalton (kDa)fragment that retains full enzymatic activity (4, 25, 62) . One border of this 29-kDa kinase domain is predicted to lie immediately N terminal to an ATP-binding site containing elements conserved between many nucleotide-binding proteins (1, 2, 63a). We have previously employed in-frame linker insertion mutagenesis as a tool to investigate the structural and functional domains of a cytoplasmic proteintyrosine kinase, the P130 gag-fps transforming protein of Fujinami sarcoma virus (FSV) (53) .
Dipeptide insertions in P130
gag-fps apparently disrupt local protein conformation in the affected structural domain without perturbing the structure of separately folding domains. Thus insertions within 250 N-terminal v-fps residues distort a fpsspecific domain and impair FSV transforming function without obvious effect on the activity of the C-terminal kinase domain (54) . A central putative hinge region accommodates insertion without effect, whereas insertions in the conserved kinase domain entirely abolish transforming ability. One FSV mutant (RX15m) with an insertion approximately 80 residues N terminal to the P130 gag-fps ATP-binding site was not easily categorized since it was unable to elicit focus formation in rat-2 cells, yet was unaltered in either the
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N-terminal fps-specific domain or the C-terminal
PROTEIN-TYROSINE KINASE DOMAINS
kinase domain (53) . We have therefore examined in detail the region immediately N terminal to the predicted kinase domain of P130
gag-fps
. In all known cytoplasmic protein-tyrosine kinases a sequence of approximately 100 amino acids N terminal to the catalytic domain is highly conserved. Here we describe FSV mutants and bacterial expression vectors designed to test the functional importance of this conserved noncatalytic domain.
MATERIALS AND METHODS
Construction of in-frame linker insertion mutations and mammalian cell expression vector. The procedure for construction of AX (AluI-*XhoI) and RX (RsaI-XhoI) linker insertion mutations in FSV with the plasmid pJ2 was reported previously (53) . The RX1Sm mutant contains an XhoI linker (CTCGAG) in the RsaI site at FSV nucleotide position 2839 (numbered according to Shibuya and Hanafusa [47] ), whereas the AX9m mutant contains one copy of an XhoI linker in the AluI site at position 2872 of the FSV sequence. Sequencing of the mutation sites was by the dideoxynucleotide chain termination method of Sanger et al. (44) . For increased expression of mutant proteins in mammalian cells we used a plasmid vector (pIV2; see Fig. 3 ) in which FSV sequences are driven from the simian virus 40 early promoter and the Neo r gene from an FSV long terminal repeat. To construct pIV2 a 4.8-kilobase (kb) SstI fragment representing the entire circularly permuted FSV genome was subcloned into pUC18 at the SstI site. The HindIII-EcoRI insert from this plasmid was ligated to the HindIII-EcoRI sites of pSV2neo (pIV1) (50) . A 2.5-kb HindIII-BamHI fragment from pSV2neo containing the Neo r gene and simian virus 40 early polyadenylation site was inserted after end filling and attachment of EcoRI linkers into the EcoRI site of pIV1.
Cell culture and DNA transfection. Rat-2 cells (58) were grown in Dulbecco modified Eagle medium supplemented with 10%o fetal bovine serum. Transfection of pJ2 or its RX15m or AX9m derivatives was as described previously (53) . Plates transfected with plasmids containing RX15m or AX9m mutant FSV genomes were maintained for 8 weeks for analysis of transforming activity. To isolate cell lines expressing equivalent amounts of wild-type (wt), RX15m, or AX9m P130 gag-fps protein, 5 x 10 6 rat-2 cells were transfected with 500 ng of pIV2 plasmid containing wt or mutant gag-fps genes plus 5 g of rat-2 carrier DNA by using the calcium phosphate coprecipitation technique. At 48 h posttransfection the cells were trypsinized and replated at a 1:20 dilution in Dulbecco modified Eagle medium containing 10% fetal bovine serum and 400 g of G418 (GIBCO Laboratories) per ml. The medium was changed every 4 to 5 days. After 4 weeks G418-resistant colonies were subcultured to 35-mm wells and subsequently analyzed for expression of p130 gagfps by metabolic labeling with [ 35 S]methionine and immunoprecipitation with anti-p9l gag monoclonal antibody. Cell lines were maintained in 200 g of G418 per ml.
Antisera. The anti-p19 gag mouse monoclonal antibody R254E has been described previously (21) . Polyclonal rabbit antisera were raised to the 37-kDa trpE product of the bacterial pATH expression vector and to the bacterial pTF822 trpE-v-fps protein (see Fig. 8 and 9 ). For this purpose 100-ml cultures of Escherichia coli RR1 induced for expression of the pATH or pTF822 proteins (see below) were lysed and electrophoresed on 10% sodium dodecyl sulfate (SDS)-polyacrylamide preparative gels. The positions of trpE or trpE-v-fps proteins were identified by staining of gel strips with Coomassie blue. Proteins were electroeluted and concentrated as described previously (24) . In each case 250 g of gel-purified protein was emulsified in complete Freund adjuvant and injected at various sites intramuscularly and subcutaneously into a 6-month-old New Zealand white rabbit. Rabbits were boosted after 5 and 10 weeks with 100 g of protein in incomplete Freund adjuvant and were bled for antiserum 7 days after the second boost.
Metabolic labeling and immunoprecipitation of mammalian cell proteins. Rat-2 cells were metabolically labeled for 4 h with [35S] methionine or with 32Pi as described previously (62) . For pulse-chase experiments, cells were labeled for 2 h with [35S]methionine followed by chases for increasing lengths of time with fresh medium containing 20 mM unlabeled methionine.
Cell lysis, immunoprecipitation of PD3 gag-fps with R254E anti-plgag mouse monoclonal antibody or with rabbit antiserum to bacterial v-
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fps protein, and analysis of immunoprecipitates by SDS-polyacrylamide gel electrophoresis and autoradiography were as described previously (21, 62) , except that for the rabbit antiserum 10 l of serum was added to each immunoprecipitation reaction and collected with 100 1 of 10% (vol/vol) heat-inactivated Staphylococcus aureus. To quantitate 35 S or 32 P radioactivity in metabolically labeled p130 gag-fps , the relevant bands were excised from the gel and counted by liquid scintillation spectrophotometry.
In vitro kinase reactions. (21) . For preparation of bacterial trpE-v-fps proteins E. coli cells containing the pTdl359 plasmids were grown and induced as described below. The pellet from a 45-ml induced culture was washed two times in 50 mM Tris hydrochloride (pH 7.5)-100 mM NaCl-10 mM MgCl2 and suspended in 800 p.1 of E. coli lysis buffer (50 mM Tris hydrochloride [pH 7.5], 0.3 M NaCl, 1% Nonidet P-40, 20 mM MgCl2). A 200-l amount of the same buffer and 2 mg of lysozyme per ml were added, and the suspension was incubated on ice for 30 min. A 200-l amount of E. coli lysis buffer and 1 mg of DNase I per ml were then added, and the suspension was held on ice for a further 60 min. The crude lysate was clarified by centrifugation at 26,000 x g for 30 min. The supernatant was then incubated with 10 1 of rabbit anti-trpE antiserum for 60 min at 4°C and for a further 30 min with 100 1 of 10% (vol/vol) S. aureus. Immune complexes were washed in kinase lysis buffer and then in 10 mM MnCl2-50 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), pH 7.5. Kinase activity was assayed in 50 l immune complex reaction containing 10 mM MnCl2, 50 mM HEPES (pH 7.5), 2.5 Ci of [y-32 P]ATP (3,000 Ci/mmol), and 5 g of aciddenatured enolase (7, 63, 64 32 pi, lysed, and immunoprecipitated with anti-p19 gag antibody. Bacterial proteins were labeled as described below. Labeled proteins were purified by electrophoresis through 7.5% SDSpolyacrylamide gels. Analysis of phosphoamino acid content and two-dimensional tryptic phosphopeptide mapping of gel-purified proteins were undertaken as described previously (62, 64 To construct pTF729, pTF729-RX15m and pTF729-AX9m, wt pJ2, or mutant RX15m and AX9m plasmid DNAs were cut with PvuII and SmaI to excise a 2.4-kb fragment containing the coding sequence of FSV P130 gag-fps from amino acid 729 to the C terminus. The blunt-ended fragments were cloned into the SmaI site of pUC8, and the resulting clones were screened for orientation. EcoRI-HindIII fragments (1.4 kb) containing the v-fps inserts were cut out of these constructs and inserted into the EcoRI-HindIII sites of pATH-i. pTF822 and pTF833 were constructed by digesting RX15m and AX9m plasmid DNAs with XhoI (which cuts at the linker insertion site in RX15m and AX9m DNA) and HindIll to generate fragments which would code for the carboxy terminus of P130 gag-fps from amino acids 822 and 833, respectively. The 3.0-kb XhoI-HindIII fragments were cloned into the SaII-HindIII sites of pUC8. The EcoRIHindIII fragments from these plasmids were cloned into pATH-11 (RX1Sm DNA) to give pTF822 or into pATH-3 (AX9m DNA) to give pTF833. The pTF893 plasmid was constructed by digesting wt FSV DNA with BspMI (which cuts at FSV nucleotide 3055) and SmaI (nucleotide position 3942). The 5' protruding overhang resulting from the BspMI digestion was filled in with the Klenow fragment of DNA polymerase I, and the 887-base-pair fragment was blunt end ligated into the SmaI site of pUC18. The fragment was subcloned into pATH-1.
In all cases, when cloning into pATH vectors the bacterial colonies were screened by analyzing whole cell protein on polyacrylamide gels and staining with Coomassie blue. Clones encoding the correctly sized protein were found to have the proper construct by restriction analysis and partial DNA sequencing.
Growth and metabolic labeling of E. coli expressing trpE-vfps fusion protein. To grow bacteria for analysis of protein expression, 1 ml of M9 minimal medium supplemented with 0.5% (wt/vol) Casamino Acids (Difco Laboratories), 10 g of thiamine B1 per ml, 20 g of tryptophan per ml, and 50 g of ampicillin per ml was inoculated for growth overnight at 37°C. A 0.1-ml sample of the overnight culture was reinoculated into 1 ml
of M9 plus Casamino Acids, thiamine, and ampicillin. The cultures were grown for 1 h at 37°C with strong aeration, and then 5 l of 1-mg/ml indole acrylic acid in ethanol was added to induce the tryptophan operon. The cultures were grown a further 2 h, and the bacteria were pelleted by centrifugation. The pellets were suspended in 25 l of SDS-urea buffer (10 mM sodium phosphate [pH 7.2], 1% [vol/vol] 2-mercaptoethanol, 1% [wt/vol]SDS, 6 M urea) and incubated at 37°C for 30 min. A 25-l amount of 2 x SDS buffer was then added, the samples were heated at 100°C for 3 min, and 15-l portions were analyzed by electrophoresis on 7.5% polyacrylamide gels.
Growth of the bacterial cells for metabolic labeling was exactly as described above. For [ 35 (29, 61) . The sequence comparison starts at the gag-abl/actin-fgr borders and extends to include approximately 37 residues in the catalytic domain up to a conserved lysine within the ATP-binding site (63a). Residues in common between two or more different cytoplasmic tyrosine kinases are depicted in bold uppercase type, and sites showing particularly strong conservation are boxed. Invariant residues are indicated with an asterisk (*). A consensus sequence is derived from this comparison of cytoplasmic tyrosine kinases, which is in turn compared with the transmembrane tyrosine kinases gp74 verB (10), gp140 v-fms (18) , and the β-subunit of the human insulin receptor (59) . For the transmembrane kinases, residues are in uppercase type where they coincide with the cytoplasmic kinase consensus sequence. Their hydrophobic transmembrane domains are boxed with a broken line. The proposed start of the catalytic kinase domain is indicated. Amino acid insertions introduced into P130 gag-fps by site-directed mutagenesis of the FSV genome are indicated above the v-fps polypeptide sequence. Sequences were aligned by eye.
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RESULTS
An amino-terminal region of sequence identity in cytoplasmic protein-tyrosine kinases. Figure  1 shows a diagrammatic comparison of the proteins encoded by FSV (p13O gag-fps ), Rous sarcoma virus (RSV; p60 v-src ), Y73 (p9O gag-yes ) Abelson murine leukemia virus (P2l gag-abl ), and Gardner-Rasheed feline sarcoma virus (p70 gagactin-fgr ), and the mouse lsk T /tck gene. These transforming proteins all have a cytoplasmic location and possess no obvious hydrophobic sequences capable of traversing the plasma membrane (15, 22, 28, 32, 38, 39-42, 47, 55, 61) . The 260 residues shared with transmembrane tyrosine kinases are depicted as the kinase domain (src homology 1), and the locations of two invariant residues are given: the principal site of tyrosine autophosphorylation (Tyr-1073 of p130 gag-fps , Tyr-416 of p6O v-src ) (19, 64) and a lysine in the ATP-binding site thought to participate in cleaving the γ phosphate of bound ATP (Lys-950 of P130 gag-fps , Lys-295 of p60 v-src ) (1, 63a). N terminal to the kinase domain lies an additional region of sequence identity comprising approximately 100 residues, which we have termed SH2 for src homology 2. It is of interest to note that in two of these kinases, P120 gag-abl and p70 gag-actin-fgr , a foreign polypeptide is fused directly N terminal to SH2. In both cases the junction of the heterologous (gag or γ-actin) sequence with abl or fgr occurs within a few residues in the consensus tyrosine kinase sequence, defining the start of the SH2 region (Fig. 2) . A detailed sequence analysis of the SH2 domain is given in Fig. 2 , starting at the actinfgr/gag-abl junctions and extending to the conserved lysine in the ATP-binding site. The comparison has been expanded to include a variety of cellular proteins related to the retroviral cytoplasmic tyrosine kinases, including the products of the human fps/fes, mouse Isk T /tck, Drosophila melanogaster src, and Caenorhabditis elegans abl genes. A consensus sequence was deduced for these viral and cytoplasmic tyrosine kinases, which is in turn aligned to show relationships between the cytoplasmic tyrosine kinases and transmembrane kinases typified by gp74 v-erbB , gpl4O v-fms , and the β subunit of the insulin receptor. and other protein-tyrosine kinases, including
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transmembrane tyrosine kinases, is located between residues 912 and 1174 of P130 gag-fps (residues 258 through 516 of p60 v-src ) and is denoted in Fig. 2 as the catalytic domain. This region of sequence identity starts at position 133 in the consensus sequence for cytoplasmic tyrosine kinases and spans approximately 260 Cterminal residues of which only the first 37, including residues thought to participate in ATP binding, are shown in Fig. 2 . Between residues 1 and 132 of the cytoplasmic tyrosine kinase consensus sequence there is no significant homology with the transmembrane tyrosine kinases. This is not surprising, since the hydrophobic segments of transmembrane kinases which link their internal catalytic sequences to extracellular domains are located only 34 residues N terminal to the proposed start of the kinase domain. In contrast the cytoplasmic tyrosine kinases evidently possess a related N-terminal sequence of about-100 residues (consensus 1-111; designated SH2) that is separated from the proposed catalytic domain by a variable stretch of 10 to 20 amino acids with a high proportion of proline and glycine residues. The first 50 residues of SH2 show particularly high sequence conservation; between consensus residues 15 and 47 (P130 gag-fps residues 820 through 845) 9 of 33 amino acids are invariant. In contrast, within the cytoplasmic tyrosine kinase ATP-binding site (consensus residues 134 through 171, P130 gag-fps residues 912 through 950) 8 of 37 amino acids are invariant. Therefore the primary structure of the N-terminal segment of SH2 has been conserved during evolution of cytoplasmic tyrosine kinases to an equivalent 
Thus the cytoplasmic tyrosine kinases share a 100-amino-acid region of sequence identity positioned N terminal to the proposed kinase domain which is completely absent from transmembrane kinases.
FSV mutants with insertions in the SH2 region of P130 gag-fps are transformation defective. We have previously described the use of a plasmid (pJ2) containing the FSV genome to engineer and analyze in-frame linker insertion mutations in the FSV-coding sequence (53). The RX15m mutant, which was predicted to contain an in-frame dipeptide insertion near the amino terminus of SH2, was previously shown to be transformation defective (53) . DNA sequencing of the mutation site confirmed that the insertion had resulted in the substitution of Tyr-821 with -Ser-Arg-Asp- (Fig. 2) . Tyr-821 is within the highly conserved region of SH2 invariant tryptophan. We obtained an addition (AX9m) in this region of P130gag-fps by inserting a Xho1 linker in pJ2 at an AluI site at FSV nucleotide 2872. The mutation in AX9m was shown by sequence analysis to encode a dipeptide insertion of Leu-Glu bet 832 and 833, of which Glu-832 is invariant (Fig. 2) . The AX9m FSV mutant was tested for transforming activity by transfection into rat-2 cells by the calcium phosphate coprecipitation technique. No foci of transformed cells were induced by either AX9m or RX15m DNAs up to 8 weeks after transfection, whereas the parental pJ2 plasmid DNA containing the wt FSV genome induced numerous foci within 20
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weeks. These mutants are therefore transformation defective in rat-2 cells.
To characterize the P130 gag-fps encoded by the RX15m and AX9m mutants we isolated rat-2 cells expressing these proteins. For the purposes of these experiments we transferred the wt FSV, RX15m, and AX9m coding sequences into a vector (pIV2) in which FSV sequences are expressed rom the simian virus 40 early promoter and a Neo r gene is transcribed from an FSV long terminal repeat (Fig. 3) . Rat-2 cells were transfected with these plasmids and selected for expression of the linked Neo r gene by growth in G418. The resulting G418-resistant colonies were isolated, cloned, and tested for the synthesis of FSV P130 gag-fps by metabolic labeling with [ 35 S] methionine and immunoprecipitation with a monoclonal antibody to pl9 gag (Fig. 4) . The NW-14, NR-7, and NA-9 cell lines synthesized wt, RX15m, and AX9m P130 gag-fps , respectively, in the ratio 1:1.2:1.3. It is interesting to note that the [ 35 S]methionine-labeled mutant proteins migrated more rapidly than wt P130 gag-fps during electrophoresis (Fig. 4 and 5) , a property which is explained by their poor phosphorylation (see below). Pulse-chase experiments 10, 13, and 16), showed that the stabilities of the wt and mutant proteins X9m P130 gag-fps were equivalent ( Fig. 5) with wt, RX15m, and AX9m p130 gag-fps having calculated half-lives of 8.4, 7.5, and 10.1 h, respectively. These data confirmed that the RX15m and AX9m P130 gag-fps were expressed to relatively abundant levels in the NR-7 and NA-9 cell lines. Morphologically NR-7 cells expressing RX15m p130 gag-fps ( Fig.  6C ) were indistinguishable from untransfected rat-2 cells (Fig. 6A) , from which values whereas NA-9 cells expressing the AX9m protein closely resembled normal rat-2 cells but showed some evidence of morphological change (Fig. 6D) . In contrast NW-14 cells containing wt P130 gag-fps had a highly transformed morphology (Fig. 6B) . In addition the NW-14 cells formed colonies in soft agar, whereas the NR-7 and NA-9 cells were unable to s 846 through grow in agar (data not shown). Thus the high-level expression of these mutant proteins was unable to elicit transformation and anchorage-independent growth of rat-2 cells.
Mutant proteins from rat-2 cells are deficient in tyrosine kinase activity and are poorly phosphorylated. The protein-tyrosine kinase activities of wt, RX15m, and AX9m P130 gag-fps
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were measured after their immunoprecipitation from the NW-14, NR-7, and NA-9 cell lines by incubation with acid-denatured enolase and [γ-32 P]ATP (Fig. 4, Table 1 ). Under these conditions wt P130 gag-fps autophosphorylates (principally at Tyr-1073) and phosphorylates enolase at a single tyrosine (7, 64) . Compared with wt P130 gag-fps (Fig. 4, lane 5) , the autophosphorylating activity of the AX9m protein was reduced approximately 10-fold, whereas its kinase activity against enolase showed a 20-fold decrease (Fig. 4, lane 7) . The in vitro kinase activity of the RX15m protein resulted in the was negligible (Fig. 4, lane 6) .
The defective enzymatic activities of the RX15m and adjacent to an AX9m P130 gag-fps in vitro suggested that they might be poorly phosphorylated at tyrosine in rat-2 cells. The cell lines expressing RX15m and AX9m P13 gag-fps were metatbolically labeled with 32 Pi and subjected to immunoprecipitation with anti-fps antiserum. The mutant proteins incorporated very little phosphate in comparison with wt P130 gag-fps (Fig. 4, Table 1 ). Phosphoamino acid analysis of the RX15m mutant protein labeled in vivo yielded principally phosphoserine, but no phosphotyrosine, whereas the AX9m protein had some phosphotyrosine in addition to phosphoserine (data not shown). This contrasted with wt P130 gag-fps , which was highly phosphorylated in transformed cells 4402 new page (Fig. 4) . Tryptic phosphopeptide analysis of wt and RX15m P130 gag-fps from 32 P-labeled cells revealed that only two minor peptides were labeled in the RX15m mutant protein (Fig. 7) . None of the principal sites of tyrosine (spots 1, 3a-c, 4, and 7) or serine (spots 5, 6, and 8) phosphorylation characteristic of wt P130 gag-fps were present. A similar phosphopeptide map is obtained when the product of a temperature-sensitive FSV is 32 P labeled at the nonpermissive temperature for transformation (35) . These results suggested that the peptide insertions had abolished not only the ability of RX15m P130 gag-fps to autophosphorylate, but also to a large extent its capacity to serve as a substrate forcellular serine-threonine-specific kinases in vivo, perhaps by affecting its location within the cell.
Expression of enzymatically active v-fps polypeptides in E. coli. Previous data have suggested that the SH2 region in FSV P130 gag-fps lies outside the C-terminal catalytic domain (62) . Paradoxically, dipeptide insertions within SH2 apparently interfered with P130 gag-fps tyrosine kinase activity and transforming function in rat-2 cells. If the SH2 domain were not critical for enzymatic activity per se we reasoned that it might be possible to resurrect the enzyme activities of the proteins encoded by the RX15m and AX9m mutants by expressing them in a different environment. We have used bacterial expression of v-fps polypeptide fragments to investigate this possibility.
To achieve synthesis of FSV polypeptides in E. coli we fused v-fps coding sequences in frame to those for trpE in the pATH bacterial expression plasmid, as detailed in Materials and Methods. Foster and Hanafusa have shown that the gag region of p130 gag-fps is dispensable for transformation, and that only FSV coding sequences 3' to an NcoI site located just proximal to the gag-fps junction are required for transforming activity (13) . By cutting FSV DNA at this NcoI site, we constructed trpE-v-fps fusions whose 100-kDa products contained 42 Nterminal trpE residues linked either to C-terminal wt v-fps amino acids (residues 359 through 
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RX15m (pTd1359-RX15m) or AX9m (pTd1359-AX9m) proteins (Fig. 8) . Additional expression vectors were constructed in which v-fps sequences were progressively deleted from the N-terminal end. For these a 37-kDa trpE leader sequence was linked to the C-terminal 454 (pTF729), 361 (pTF822), 350 (pTF833), or 289 (pTF893) amino acids of P130 gag-fps (Fig. 8) . The pTF729 trpE-vfps protein contained both the SH2 and kinase domains of wt v-fps; this plasmid was also constructed from RX15m and AX9m v-fps sequences. The pTF822 and pTF833 plasmids were constructed from RX15m and AX9m, whereas pTF893 was obtained from wt v-fps.
After induction of the trp operon with indole acrylic acid, bacteria harboring these plasmids expressed novel polypeptides with the predicted molecular weights which were readily detected by Coomassie blue staining (Fig. 9) . Incubation of induced bacteria with 32 Pi for 20 min resulted in radiolabeling of both wt and mutant trpE-v-fps proteins (Fig. 9 ). This suggested that the trpE-v -fps proteins were capable of autophosphorylation in bacteria. Phosphoamino acid analysis of the 32 P-labeled polypeptide encoded by the pTF822 trpE-v-fps vector yielded phosphotyrosine as the only phosphoamino acid (data not shown). The metabolically labeled pTF822 protein (P78 trpE-fpS ) was compared with P130 gag-fps isolated from 32 Plabeled FSV-transformed rat cells by tryptic phosphopeptide analysis. In rat-2 cells wt P130 gag-fps is autophosphorylated within its v-fps region at Tyr-1073 (contained within tryptic phosphopeptides 3a through c) (Fig. 7) and on at least one further tyrosine contained within peptides 4 and 7 (62, 64) . The pTF822 4404 VOL. 6, 1986 4404 SADOWSKI ET AL.
protein from 32 P-labeled bacteria contained peptides 3a through c, 4, and 7, but lacked P130 gag-fps peptides containing phosphoserine (i.e., 5, 6, and 8) or derived from the gag region (spot 1) (Fig. 7) . The origin of several minor phosphopeptides specific to P78 trpE-fps is unknown. It is apparent from these data that the bacterial trpE-v-fps proteins are enzymatically active, as manifested by their ability to autophosphorylate in vivo at physiological tyrosine sites.
Mutant v-fps bacterial polypeptides are enzymatically active. The 100-kDa trpE-v-fps (P100 trpE-fps ) products of pTd1359, pTd1359-RX15m, and pTdl359-AX9m were phosphorylated to the same extent in E. coli (Fig.  9, Table 1 ). Since cells were only labeled for 20 min, this incorporatio seemed likely to reflect the enzymatic activities of the bacterial proteins. By this measure there was no functional distinction between wt, RX15m, and AX9m v-fps polypeptides in bacteria, in contrast to the impaired autophosphorylation of RX15m and AX9m P130 gag-fps in rat-2 cells. Similarly the phosphorylation of the pTF729 trpE-v-fps proteins was equivalent regardless of whether they contained wt, RX15m, or AX9m sequences (Fig. 9) . We conclude that the insertions in SH2 do not materially affect v-fps kinase activity in the milieu of the bacterial cell.
To test the relative kinase activities of these bacterial proteins in vitro, cells expressing fulllength wt, RX15m, or AX9m P100 trpE-fps proteins were lysed, and insoluble material was removed by centrifugation. The soluble P100 trpE-fps proteins were immunoprecipitated with antiserum to the N-terminal trpE region, and immunoprecipitates were incubated with [γ-32 P]ATP and aciddenatured enolase (Fig. 10, Table 1 ). Compared with wild-type P100 trpE-fps the mutant proteins encoded by pTdl359-RX15m or pTdl359-AX9m were equivalent in autophosphorylation and showed a two-to fourfold decrease in enolase phosphorylation. Thus relative to wt the mutant proteins were at least 10-fold more active in both autophosphorylation and enolase phosphorylation in bacteria than in rat-2 cells. As a further test of the in vitro activities of the trpE-v-fps proteins, crude bacterial lysates were incubated with a poly (Glu,Tyr) polymer in the presence of [γ-32 P]ATP. The phosphorylated poly(Glu,Tyr) was isolated by electrophoresis on a non-SDS denaturing gel. No significant difference was found in the tyrosine kinase activities of bacterial extracts containing wt, RX15m, or AX9m pTd1359 trpEv-fps proteins (Table 1) .
The SH2 region is not required for kinase activity. The v-fps regions of the pTF822 and pTF833 expression plasmids (Fig.   FIG. 7 . Tryptic phosphopeptide analysis of P130 gag-fps and bacterial v-fps proteins. wt or RX15m P130 gag-fps were isolated by immunoprecipitation from 32 P-labeled rat-2 cells. The 78-kDa trpE-v-fps product of the pTF822 plasmid (P78 trpE-fps ) was isolated from extracts of 32 P-labeled induced bacteria. v-fps proteins from mammalian and bacterial cells were eluted from SDS-polyacrylamide gels, oxidized, and digested with trypsin. Tryptic digests were separated in two dimensions by electrophoresis at pH 2.1 from left to right (anode to the left) and chromatography in N-butanolacetic acid-water-pyridine (15:3:12:10) from bottom to top. Peptide maps were exposed to X-ray film in the presence of an intensifying screen for 14 days (wt and RX15m P130 gag-fps ) or for 18 h (P78 trpE-fps ). In the phosphopeptide map of wt FSV PD30 gag-fps spots 1, 3a through c, 4, and 7 contain phosphotyrosine, whereas spots 5, 6, and 8 contain phosphoserine (62) (63) (64) . The identity of spots 3a through c, 4, and 7 in P78 trpE-fps was confirmed by comigration with a tryptic digest of wt P130 gag-fps. The phosphopeptides of RX15m did not comigrate with any major spots of wt P130 gagfps. 8) were derived from RX15m and AX9m, respectively, by cutting these DNAs at the insertion mutation XhoI sites. Their encoded products contain only v-fps sequences C terminal to the insertion sites and are missing the most Nterminal part of SH2. Nonetheless these trpE-vfps proteins autophosphorylate efficiently in bacteria in comparison with the products of pTd1359 or pTF729 (Fig. 9) . The plasmid pTF893 was derived from wt v-fps sequences and encodes a trpE-v-fps protein that is missing virtually all of Ic SH2 (Fig. 8) . This polypeptide was also phosphorylated in vivo (Fig. 9) . Thus the SH2 region can be partially or almost completely removed without ablating or markedly affecting v-fps kinase activity in bacteria.
DISCUSSION
Here we describe a polypeptide sequence of approximately 100 residues which is shared between all known cytoplasmic protein-tyrosine kinases but is absent from tyrosine kinases which span the plasma membrane. This domain (here designated SH2) lies immediately N terminal to the catalytic sequences conserved between cytoplasmic protein-tyrosine kinases and other protein kinases and might be thought to interact with or constitute an ancillary part of the kinase domain. This notion is supported by the observation that mutations which introduce dipeptide insertions into the SH2 region of FSV P130 gag-fps impair FSV transforming ability and P130 gag-fps kinase activity in rat-2 cells. The LeuGlu insertion in AX9m was expected to be less disruptive of protein structure than the substitution of Tyr-821 with Ser-Arg-Asp in RX15m (Fig. 2) ; indeed AX9m P130 gag-fps proved to have residual kinase activity and to induce a minor morphological change in rat cells, whereas the RX15m protein was enzymatically and functionally inert. From this it might be assumed that these mutations are in a region required for catalytic activity and induce local conformational changes in the v-fps kinase domain which directly abolish enzymatic function. This simplistic view is challenged by the observation that mutant v-fps polypeptides containing the peptide insertions have full tyrosine kinase FIG. 9 . Expression and phosphorylation of trpE-v-fps proteins in E. coli. E. coli bacteria containing expression plasmids were induced for 2 h with indole acrylic acid, metabolically labeled with 32 Pi, lysed in SDS-urea buffer, and analyzed by electrophoresis through 7.5% (A and B) or 10%6 (C) SDS-polyacrylamide gels. Proteins were identified by staining with Coomassie blue and phosphoproteins on the same gel were located by autoradiography. The trpE and trpE-v-fps proteins are indicated by arrows, and the molecular weights of size markers (x 103) are indicated. A, E. coli bacteria containing pTd1359 (lanes 1 and 4), pTdl359-RX15m (lanes 2 and 5), or pTdl359-AX9m (lanes 3 and 6) were analyzed for Coomassie blue-stained proteins (lanes 1 through 3) and by autoradiography for 32 P-labeled proteins (lanes 4 through 6) . B, E. coli bacteria containing the pATH parental plasmid, which encodes a 37-kDa trpE polypeptide (lanes 1 and 7), pTF729 (lanes 2 and 8), pTF729-RX15m (lanes 3 and 9), pTF729-AX9m (lanes 4 and 10), pTF822 (lanes 5 and 11), or pTF833 (lanes 6 and 12) were analyzed as above for total protein (lanes 1 through 6) and phosphoproteins (lanes 7 through 12). C, E. coli bacteria containing pTF833 (lanes 1 and 3) or pTF893 (lanes 2 and 4) were analyzed for total protein (lanes 1 and 2) or phosphoproteins (lanes 3 and 4).
SADOWSKI ET AL.
FIG. 10. In vitro kinase activities of wt, RX15m, and AX9m P100 trpE-fps bacterial proteins. E. coli bacteria containing the pTd1359 (lane 1), pTdl359-RX15m (lane 2), or pTdl359-AX9m (lane 3) plasmids were grown, and expression of the P100 trpE-fps proteins was induced for 2 h. Bacterial cells were lysed, and the clarified lysates were immunoprecipitated with rabbit anti-trpE antiserum. Immune complexes were incubated with [γ-32 P]ATP and 5 μg of acid-denatured enolase, and the in vitro reaction products were analyzed by SDS-polyacrylamide gel electrophoresis and autoradiography. activity when expressed in bacteria, as do v-fps polypeptides lacking part or all of SH2. In contrast we have found that substitution of an essential lysine in the v-fps ATP-binding site with arginine destroys tyrosine kinase activity of trpEv-fps proteins in E. coli (unpublished observation). Thus the integrity of the SH2 domain is apparently not of itself required for kinase activity, since the loss of kinase function is only observed when SH2 insertion mutants are expressed in rat-2 cells. It is likely that the SH2 domain of p130 gag-fps can make contact with the catalytic region, and peptide insertions in SH2 might therefore directly disrupt the native conformation of the nearby kinase domain. However in this case we would have expected the bacterial trpE-v-fps proteins containing the insertions to also lack activity. Rather, these observations suggest that SH2 is a noncatalytic domain involved in an interaction with components specific to the vertebrate cell and by virtue of this interaction can modulate kinase activity.
A body of evidence supports the notion that SH2 is not essential for catalytic activity but may have some important role in directing the cellular actions of the kinase domain. Partial trypsinolysis of p60 v-src , P130 gag-fps and p90 gag-yes can yield enzymatically active fragments of 29 to 30 kDa which are apparently derived from the extreme C termini of these proteins and must therefore lack SH2 sequences (4, 25, 62) . For RSV, a number of mutations in the coding region for the aminoterminal half of p60 v-src impair transforming activity with little obvious effect on tyrosine kinase function. A v-src mutant protein with a deletion of residues 15 through 149 (to residue 16 in the consensus sequence in Fig. 1 ) induced a fusiform transformed morphology in chicken embryo fibroblasts, whereas deletions of p60 v-src amino acids 149 through 169 (consensus residues 16 through 39) or 135 through 237 (consensus residues 2 through 107) had a more markedly deleterious effect on RSV transforming potential (9, 23) . The proteins encoded by these mutants had essentially normal levels of tyrosine kinase activity in chicken cells. It is of interest that the vsrc residues 149 through 169 lost in the RSV deletion mutant NY320 correspond to a region in P130 gag-fps (amino acids 821 through 839) within which the RX15m and AX9m linker insertion mutations are located. A second class of RSV mutants with structural alterations in the aminoterminal half of p60 v-src are temperature sensitive for transformation (6, 52) . The p60 v-src of one such mutant (LA32) showed no appreciable loss of kinase activity at the nonpermissive temperature (52), whereas another (tsCH119) with a deletion of p60 v-src residues 173 through 227 (consensus residues 38 through 98) had only a 50% decline in kinase activity at 41°C (6) . For Abelson murine leukemia virus, mutations which infringe on the SH2 domain largely abolished transforming activity (36). Deletion of the first 28 abl-encoded residues of P120 gag-abl (consensus residues 4 through 32) resulted in diminished kinase activity and loss of transforming function, whereas peptide insertions between consensus residues 7 through 8 and 18 through 19 had little effect (36).
These observations for RSV and Abelson murine leukemia virus are generally consistent with the notion that the SH2 domain is not critical for kinase activity but plays an important role in transformation. The sequence comparison of cytoplasmic protein-tyrosine kinases provides two circumstantial arguments to validate the suggestion that the SH2 domain is important for the transforming activity of oncogenic proteins and the functions of their normal counterparts. First, the precise retention of the same SH2 sequences during the recombination of viral and cellular sequences in the formation of the Abelson murine leukemia virus and Gardner-Rasheed feline sarcoma virus genomes argues for their functional significance. Second, the SH2 noncatalytic domain has been retained in every known viral and cellular cytoplasmic tyrosine kinase and is highly conserved between such kinases from evolutionarily distant species. The concentration of invariant residues in the Nterminal half of SH2 suggests that functional constraints have operated to preserve the SH2 structural motif.
What are the actual functions of the SH2 region? It must fulfill a common requirement of cytoplasmic tyrosine kinases involving a functional interaction with the kinase domain. Indirect evidence suggests that SH2 does associate with the catalytic region. The principal protease-resistant fragment produced by mild chymotrypsin or trypsin digestion of P130 gag-fps is an enzymatically active polypeptide of 45 kDa, which presumably represents a structural unit that includes both SH2 and kinase domains. This 45-kDa polypeptide can be converted to 29-to 33-kDa active fragments by further trypsinolysis which separates SH2 from the catalytic domain (62; unpublished results). As argued above, our data raise the possibility that the proposed interaction of SH2 with the catalytic domain is modified by cellular components that associate with SH2. These might be tyrosine kinase substrates or regulatory proteins. After their synthesis p60v-src, P130 gag-fps , and P90 gag-yes (but not transmembrane tyrosine kinases) all transiently associate with a 90-kDa heat shock protein and a 50-kDa tyrosine kinase substrate to form a complex which has been implicated in transport of the transforming proteins to the membrane (3, 5, 26, 34) . In p60 v-src a sequence encompassing residues 155 through 160 (consensus residues 22 through 27) within the SH2 region of p60 v-src may be involved in binding of the 50-kDa cellular protein (56) . Interestingly p60vsrc is reported to have little kinase activity when associated with the complex (5). It is possible that in mammalian cells the interactions of the mutant P130 gag-fps proteins with this complex or with other regulatory proteins are perturbed and they are therefore 4407 unable to assume a final active form. Since P130 gag-fps kinase activity is stimulated by autophosphorylation at Tyr-1073 (64), a further possibility is that the SH2 domain influences the extent of P130 gag-fps autophosphorylation and thereby indirectly regulates catalytic activity toward exogenous substrates. The insertions in the RX15m and AX9m proteins could decrease the stoichiometry of P139 gag-fps autophosphorylation in rat cells, for example by increasing sensitivity to phosphotyrosyl phosphatases. The same mutant proteins in bacterial cells, which lack specific phosphotyrosyl phosphatases, might accumulate phosphorylated tyrosine and be converted to an enzymatically active form. Regarding substrate binding, it is of interest that the bacterial mutant proteins are equivalent to the wt proteins in autophosphorylation and poly(Glu,Tyr) phosphorylation but have somewhat decreased ability to phosphorylate the physiological substrate enolase in vitro. Experiments to explore the functions of the SH2 domain and to identify cellular proteins with which it interacts are in progress. 
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